WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1632972 PLYMOUTH, MN

Position in ZNTL

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$333,757

+$149,506 QoQ

Shares Held

68,816

-12.6% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 2 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. ZNTL ranks #63 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$333,757	68,816	-12.6%	Shares	Sole	2026-07-15
2026-03-31	$184,251	78,740	-39.6%	Shares	Sole	2026-04-08
2025-12-31	$176,049	130,407	-21.6%	Shares	Sole	2026-01-08
2025-09-30	$251,097	166,290	-4.4%	Shares	Sole	2025-10-29
2025-06-30	$201,846	174,006	-25.7%	Shares	Sole	2025-07-10
2025-03-31	$372,172	234,071	+17.0%	Shares	Sole	2025-04-16
2024-12-31	$606,342	200,113	+194.7%	Shares	Sole	2025-03-17
2024-09-30	$249,846	67,893	+44.3%	Shares	Sole	2024-10-24
2024-06-30	$192,414	47,045	+9.0%	Shares	Sole	2024-07-16
2024-03-31	$680,438	43,175	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.